Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Barycela vs Varivax in Healthy Children
NCT07054099Phase 3Recruiting
- Sponsor
- GC Biopharma Corp
- Start
- Mar 2026
- Primary completion
- Aug 2027
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of varicella virus vaccine live in varicella (VZV), sponsored by GC Biopharma Corp. Started Mar 2026; status: recruiting.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT07054099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07054099.